ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,731, issued on Oct. 14, was assigned to Incyte Corp. (Wilmington, Del.).

"Pyrazolopyrimidine compounds and uses thereof" was invented by Oleg Vechorkin (Wilmington, Del.), Minh Nguyen (Claymont, Del.), Chao Qi (Newark, Del.), Anlai Wang (Wilmington, Del.), Liangxing Wu (Wilmington, Del.), Wenqing Yao (Chadds Ford, Pa.) and Peng Zhao (Newark, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting ALK2 activity and/or FGFR activity, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or dis...